INSIGHTS ON CLINICAL TRIAL DESIGN

• Evaluating Adaptive Trials: Do They Align With Your Study's Goals?

  In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.

• Enhancing Clinical Trial Flexibility

  Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.

• Reassure Patients About Benefits Of Clinical Trial Participation

  Gaining a patient’s trust is the first step to trial participation. Find out how to address this in From Cautious to Committed, the first of a three-part webinar series covering strategies across the patient recruitment continuum.

• Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution

  Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.

• 5 Proven Ways To Expand Clinical Trial Site Capacity

  9/18/2025

  How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?

• Ophthalmology Assessments Made Simple: A Guide For Clinical Trials

  1/29/2025

  Explore the importance and requirements of ophthalmology assessments as well as the key challenges that complicate their implementation at clinical sites.

• 5 Essential Steps To Implementing Decentralized Clinical Trials Globally

  9/15/2025

  Running a global decentralized clinical trial requires a strategy that balances the FDA's focus on technology accessibility with the EMA's emphasis on validation and comprehensive documentation.

• How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch

  5/26/2026

  Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.

• GSK And Medable Discuss The Next Phase Of DCTs

  3/10/2025

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.